Pablo Salinas MD, PhD, is Interventional Cardiologist at the Hospital Clinico San Carlos in Madrid. He has a clinical and research interest in complex PCI (especially CTO and Left Main PCI), device therapies for stroke prevention and pulmonary embolism. He is the author or co-author of >60 articles and is currently principal investigator of 2 ongoing multicenter studies (REVASEC and SUGAR Trial). He started the local pulmonary embolism interventional program and set up a PERT team. He is regularly involved in local and international educational meetings focused on complex PCI, device therapies for stroke prevention and acute pulmonary embolism interventional management